Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-015724

President, R&D sold 8,000 shares at $23.88 ($191,040)

  • President, R&D acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-03-01 Option exercise +8,000 $4.12 $32,960 102,926 D
Bergstrom Donald A President, R&D 2022-03-01 Sale −8,000 $23.88 $191,040 94,926 D
Derivatives
Bergstrom Donald A President, R&D 2022-03-01 Option exercise · Stock Option (Right to Buy) −8,000 237,456 D
Open-market sales · 8,000 sh · avg $23.88 · $191,040
Loading xslF345X03/doc4.xml…